Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma

Title
Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Cancer Discovery
Volume -, Issue -, Pages CD-19-0367
Publisher
American Association for Cancer Research (AACR)
Online
2019-10-02
DOI
10.1158/2159-8290.cd-19-0367

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started